Research landmarks on the 60th anniversary of Epstein-Barr virus

Lan-Yi Zhong^#¹, Chu Xie^#¹, Le-Le Zhang^#¹, Yan-Lin Yang^#¹, Yuan-Tao Liu^#¹, Ge-Xin Zhao¹, Guo-Long Bu¹, Xian-Shu Tian¹, Zi-Ying Jiang¹, Bo-Yu Yuan¹, Peng-Lin Li¹, Pei-Huang Wu¹, Wei-Hua Jia¹, Christian Münz², Benjamin E Gewurz^{3

4

5

6}, Qian Zhong¹, Cong Sun⁷, Mu-Sheng Zeng⁸

Affiliations

¹ State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
² Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, 8092, Switzerland.
³ Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
⁴ Department of Microbiology, Harvard Medical School, Boston, MA, 02115, USA.
⁵ Harvard Program in Virology, Boston, MA, 02115, USA.
⁶ Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.
⁷ State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. suncong@sysucc.org.cn.
⁸ State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. zengmsh@sysucc.org.cn.

^# Contributed equally.

PMID: 39505801
DOI: 10.1007/s11427-024-2766-0

Review

Research landmarks on the 60th anniversary of Epstein-Barr virus

Lan-Yi Zhong et al. Sci China Life Sci. 2025 Feb.

. 2025 Feb;68(2):354-380.

doi: 10.1007/s11427-024-2766-0. Epub 2024 Nov 4.

Authors

Affiliations

¹ State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
² Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, 8092, Switzerland.
³ Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
⁴ Department of Microbiology, Harvard Medical School, Boston, MA, 02115, USA.
⁵ Harvard Program in Virology, Boston, MA, 02115, USA.
⁶ Broad Institute of Harvard and MIT, Cambridge, MA, 02142, USA.
⁷ State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. suncong@sysucc.org.cn.
⁸ State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China. zengmsh@sysucc.org.cn.

^# Contributed equally.

PMID: 39505801
DOI: 10.1007/s11427-024-2766-0

Abstract

Epstein-Barr virus (EBV), the first human oncovirus discovered in 1964, has become a focal point in virology, immunology, and oncology because of its unique biological characteristics and significant role in human diseases. As we commemorate the 60th anniversary of EBV's discovery, it is an opportune moment to reflect on the major advancements in our understanding of this complex virus. In this review, we highlight key milestones in EBV research, including its virion structure and life cycle, interactions with the host immune system, association with EBV-associated diseases, and targeted intervention strategies.

Keywords: Epstein-Barr virus; antibodies; epidemiology; immune response; oncovirus; vaccines.

PubMed Disclaimer

Conflict of interest statement

Compliance and ethics. The authors declare that they have no conflict of Interest.

References

1. Ablasser, A., Bauernfeind, F., Hartmann, G., Latz, E., Fitzgerald, K.A., and Hornung, V. (2009). RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10, 1065–1072. - PubMed
1. Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A.D., Araujo, I.B.O., Berti, E., Bhagat, G., Borges, A.M., Boyer, D., Calaminici, M., et al. (2022). The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36, 1720–1748. - PubMed - PMC
1. Albanese, M., Tagawa, T., and Hammerschmidt, W. (2022). Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host. Front Microbiol 13, 955603. - PubMed - PMC
1. Ansari, M.A., Singh, V.V., Dutta, S., Veettil, M.V., Dutta, D., Chikoti, L., Lu, J., Everly, D., and Chandran, B. (2013). Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol 87, 8606–8623. - PubMed - PMC
1. Apcher, S., Komarova, A., Daskalogianni, C., Yin, Y., Malbert-Colas, L., and Fåhraeus, R. (2009). mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1. J Virol 83, 1289–1298. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Research Materials
- NCI CPTC Antibody Characterization Program

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Research landmarks on the 60th anniversary of Epstein-Barr virus

Affiliations

Research landmarks on the 60th anniversary of Epstein-Barr virus

Authors

Affiliations

Abstract

Conflict of interest statement

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Research Materials